The role of the MTHFR gene in migraine

Shani Stuart1, Hannah C Cox, Rod A Lea

  • 1Genomics Research Centre, Griffith Health Institute, Griffith University, Gold Coast Campus, Southport, QLD, Australia.

Headache
|March 2, 2012
PubMed

Insights

Researchers identified three methylenetetrahydrofolate reductase (MTHFR) gene variants associated with migraine susceptibility in a unique population. This finding reinforces the MTHFR gene's role in the complex neurological disorder, migraine.

Area of Science:

  • Neuroscience
  • Genetics
  • Vascular Biology

Background:

  • Migraine is a prevalent neurological disorder with diverse symptoms, including head pain, nausea, and photophobia.
  • Genetic factors, particularly those influencing vascular regulation, are implicated in migraine pathogenesis.
  • The methylenetetrahydrofolate reductase (MTHFR) gene is of significant interest, especially in migraine with aura, which has links to stroke.

Purpose of the Study:

  • To investigate the role of the methylenetetrahydrofolate reductase (MTHFR) gene in migraine.
  • To explore MTHFR genetic variants within a specific population isolate.
  • To identify potential genetic markers for migraine susceptibility.

Main Methods:

  • Analysis of MTHFR gene single nucleotide polymorphisms (SNPs) in the Norfolk Island population.
  • Utilizing a genetic isolate to enhance the study of specific genetic variants.
  • Investigating the association between identified MTHFR SNPs and migraine.

Main Results:

  • Three specific MTHFR single nucleotide polymorphisms (SNPs) were found to be associated with migraine in the study population.
  • These findings provide evidence supporting the involvement of MTHFR in migraine susceptibility.
  • The study highlights the utility of genetic isolates for investigating complex diseases.

Conclusions:

  • The methylenetetrahydrofolate reductase (MTHFR) gene plays a potential role in migraine susceptibility.
  • Further research is needed to build a comprehensive genetic profile for migraine.
  • Understanding the genetic underpinnings of migraine can lead to improved insights into its complex etiology.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life